No hay productos en el carrito



Hematopoietic Growth Factors in Oncology
Lyman, G. — Dale, D.
1ª Edición Noviembre 2010
Inglés
Tapa dura
435 pags
1200 gr
16 x 24 x 2 cm
ISBN 9781441970725
Editorial SPRINGER
LIBRO IMPRESO
-5%
207,99 €197,59 €IVA incluido
199,99 €189,99 €IVA no incluido
Recíbelo en un plazo de
2 - 3 semanas
About this book
No area of cancer supportive care better illustrates the advances in our understanding
of cellular and molecular biology, genetic engineering and the development of
more effective yet often more toxic cancer treatments than that of hematopoietic
growth factors. Myelosuppressive agents, with their potential hematopoietic
toxicities, remain the mainstay of systemic treatment for both metastatic and
early stage cancer. Hematopoietic Growth Factors in Oncology reviews and integrates
the major advances in our understanding of the underlying molecular biology
and pharmacology of these agents along with the results of well designed and
executed randomized controlled trials of the erythroid stimulating agents, the
myeloid growth factors and the new thrombopoietic agents, each addressing a
major threat associated with bone marrow suppression accompanying cancer treatment.
"Hematopoietic growth factors have revolutionized the treatment of patients
with a spectrum of cancers and benign bone marrow disorders. This text addresses
the mechanism of action and clinical impact of these cytokines. Leading investigators
in the field provide and update of current state of knowledge and future challenges."
– Steven T. Rosen, M.D. Series Editor
Content Level » Professional/practitioner
Keywords » Biology - Molecular Genetics - Pharmacology
Related subjects » Oncology & Hematology
© 2025 Axón Librería S.L.
2.149.0